Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells.
<h4>Background</h4>Canine urothelial carcinoma is the most common form of canine bladder cancer. Treatment with chemotherapy has variable response rates leading to most dogs succumbing to their disease within a year. Cannabidiol is an emerging treatment within the field of oncology. In r...
Guardado en:
Autores principales: | Jordon M Inkol, Samuel E Hocker, Anthony J Mutsaers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c664f96fd7544fcb2ea5f18529eb020 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetic instability persists in non-neoplastic urothelial cells from patients with a history of urothelial cell carcinoma.
por: João Paulo de Castro Marcondes, et al.
Publicado: (2014) -
The antimicrobial potential of cannabidiol
por: Mark A. T. Blaskovich, et al.
Publicado: (2021) -
Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines.
por: Franziska Weiner, et al.
Publicado: (2021) -
Treatment Strategy for Dialysis Patient with Urothelial Carcinoma
por: Yun-Ching Huang, et al.
Publicado: (2021) -
Morphological predictors for microsatellite instability in urothelial carcinoma
por: Eduardo Sobrino-Reig, et al.
Publicado: (2021)